Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?

Page 2 of 2

Now, some big names have jumped into Karyopharm Therapeutics Inc (NASDAQ:KPTI) headfirst. D E Shaw, managed by D. E. Shaw, established the biggest position in Karyopharm Therapeutics Inc (NASDAQ:KPTI). D E Shaw had $0.5 million invested in the company at the end of the quarter. Glenn Russell Dubin’s Highbridge Capital Management also initiated a $0.4 million position during the quarter. The other funds with brand new KPTI positions are Matthew Hulsizer’s PEAK6 Capital Management and Dmitry Balyasny’s Balyasny Asset Management.

Let’s go over hedge fund activity in other stocks similar to Karyopharm Therapeutics Inc (NASDAQ:KPTI). We will take a look at Davids Tea Inc (NASDAQ:DTEA), NewStar Financial Inc (NASDAQ:NEWS), Resource Capital Corp. (NYSE:RSO), and Univest Corp. of PA (NASDAQ:UVSP). This group of stocks’ market values match KPTI’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
DTEA 4 2238 -3
NEWS 8 108742 1
RSO 7 7715 -4
UVSP 5 6205 -1

As you can see these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $31 million. That figure was $65 million in KPTI’s case. NewStar Financial Inc (NASDAQ:NEWS) is the most popular stock in this table with a total of eight funds reporting long positions. On the other hand, Davids Tea Inc (NASDAQ:DTEA) is the least popular one with only 4 bullish hedge fund positions. Compared to these stocks Karyopharm Therapeutics Inc (NASDAQ:KPTI) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Page 2 of 2